<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01947673</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00066932</org_study_id>
    <secondary_id>00025948</secondary_id>
    <nct_id>NCT01947673</nct_id>
  </id_info>
  <brief_title>Mechanisms of Intradialytic Hypertension</brief_title>
  <acronym>MID-H</acronym>
  <official_title>Sympathetic Regulation in Intradialytic Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Satellite Healthcare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Emory University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with end-stage renal disease (ESRD) are at significantly higher risk for death due&#xD;
      to cardiovascular disease. Those with paradoxical increases in blood pressure (BP) during&#xD;
      hemodialysis (HD), defined as intradialytic hypertension (IDH), are at even greater risk of&#xD;
      cardiovascular mortality. This study seeks to determine the mechanisms that underlie IDH, and&#xD;
      whether mindfulness meditation might improve BP during dialysis in these patients. The&#xD;
      investigators will first determine if increased adrenaline levels during volume removal&#xD;
      contributes to IDH. The investigators will then determine lack of suppression of adrenaline&#xD;
      levels in the setting of a high BP also contributes to IDH. This will be done by manipulating&#xD;
      blood pressure by using small amounts of vasoactive drugs, and determining if an appropriate&#xD;
      response in adrenaline levels occurs. Lastly, the investigators will determine if an&#xD;
      intradialytic mindfulness meditation program improves BP and adrenaline levels in ESRD&#xD;
      patients with IDH.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2013</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Pressure during dialysis</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiopulmonary baroreflex Sensitivity</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Kidney Disease Quality of Life (KDQOL) Symptom Score</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Renal Failure Chronic Requiring Hemodialysis</condition>
  <condition>Haemodialysis-induced Symptom</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Modified Mindfulness Based Stress Reduction (MBSR) Program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After individual instruction, participants in this arm will perform meditation by following a series of mindfulness meditation (MM) recordings during hemodialysis for the next 4 to 8 weeks.The MM instructor will also meet with the participants weekly to provide continued instruction. Participants will also be encouraged to perform MM using a digital audio (MP3) player at home on non-dialysis days, and asked to keep a log of these sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health Education</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants randomized to the control condition will undergo a 4 to 8 week health education series, with a parallel protocol as the MBSR intervention. Monitoring of adherence will be same as above.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Mindfulness Meditation</intervention_name>
    <arm_group_label>Modified Mindfulness Based Stress Reduction (MBSR) Program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Health Education</intervention_name>
    <arm_group_label>Health Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ESRD patients on maintenance hemodialysis for at least 6 months, with increased blood&#xD;
             pressure during hemodialysis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  drug or alcohol abuse&#xD;
&#xD;
          -  any serious systemic disease that might influence survival&#xD;
&#xD;
          -  severe anemia with hgb level &lt;8 g/dL&#xD;
&#xD;
          -  clinical evidence of congestive heart failure&#xD;
&#xD;
          -  ejection fraction below 35%&#xD;
&#xD;
          -  myocardial infarction or cerebrovascular accident within the past six months&#xD;
&#xD;
          -  symptomatic heart disease determined by electrocardiogram, stress test, and/or history&#xD;
&#xD;
          -  treatment with central alpha agonists or monoamine oxidase (MAO) inhibitors&#xD;
&#xD;
          -  peripheral neuropathy&#xD;
&#xD;
          -  autonomic dysfunction&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  surgery within the past 3 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeanie Park, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory Dialysis Clinics</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 18, 2013</study_first_submitted>
  <study_first_submitted_qc>September 19, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2013</study_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Emory University</investigator_affiliation>
    <investigator_full_name>Jeanie Park</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

